Interpretation of guideline for diagnosis and treatment of liver failure （2024 version）
Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 12
Abstract
In 2024， Liver Failure and Artificial Liver Group， Chinese Society of Infectious Diseases， Chinese Medical Association and Chinese Society of Hepatology， Chinese Medical Association updated Guideline for diagnosis and treatment of liver failure （2018 version）. Guideline for diagnosis and treatment of liver failure （2024 version） covers the definition and etiology of liver failure， the classification and diagnosis of liver failure， the treatment of liver failure， and future prospects. This article gives an interpretation of the updated key points in the new edition of the guideline， in order to better guide the management of liver failure in clinical practice.
Authors and Affiliations
Tao HAN
Keywords
Related Articles
- EP ID EP753956
- DOI 10.12449/JCH241207
- Views 43
- Downloads 0
Expert consensus on the sequential surgery following conversion therapy based on the combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma （2024 edition）
Up to half of patients with hepatocellular carcinoma （HCC） in China are diagnosed at an advanced stage and often with a dismal prognosis. More effective treatment strategies are mandatory. In recent years， the combina...
Hepatitis flare and treatment in postpartum women with chronic hepatitis B virus infection
Hepatitis flare can happen in postpartum women with chronic hepatitis B virus （HBV） infection due to the changes in immune function and hormone levels. In order to delay disease progression in parturients and ensure th...
Functional cure of chronic hepatitis B is not a dream
Functional cure of chronic hepatitis B （CHB） is defined as HBsAg<0.05 IU/mL and serum HBV DNA<10 IU/mL for at least 24 weeks after discontinuation of antiviral therapy. This requires suppression of HBV replication and...
Systemic therapy for advanced hepatocellular carcinoma
Hepatocellular carcinoma （HCC） is one of the most common malignancies with high morbidity and mortality rates worldwide. With the advances in molecular biology and tumor immunology， molecular-targeted agents represent...
New advances in antiviral therapy during pregnancy to block mother-to-child transmission of hepatitis B virus
Mother-to-child transmission of hepatitis B virus （HBV） is one of the primary causes of the high disease burden of chronic hepatitis B in China， and blocking this route of transmission has an important strategic signi...